Fumiaki Kato
- Pulmonary and Respiratory Medicine top 10%
- Cardiology and Cardiovascular Medicine
- Molecular Biology
- Surgery
- Oncology
- Co-authors
- Koichiro TatsumiRintaro NishimuraSeiichiro SakaoNobuhiro TanabeKazuki NabeshimaAkinori IwasakiMakoto HamasakiAyumi Sekine
- Topics
- Pulmonary Hypertension Research and Treatments (13 papers)Pleural and Pulmonary Diseases (4 papers)Lung Cancer Diagnosis and Treatment (4 papers)
- Journals
- Journal of Clinical OncologyPLoS ONEAmerican Journal of Physiology-Lung Cellular and Molecular Physiology
- Partner nations
- JapanUnited States
In The Last Decade
Fumiaki Kato
28 papers receiving 318 citations
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 242
- Cardiology and Cardiovascular Medicine 103
- Molecular Biology 56
- Surgery 44
- Oncology 42
Countries citing papers authored by Fumiaki Kato
This map shows the geographic impact of Fumiaki Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Kato more than expected).
Fields of papers citing papers by Fumiaki Kato
This network shows the impact of papers produced by Fumiaki Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Kato. The network helps show where Fumiaki Kato may publish in the future.
Co-authorship network of co-authors of Fumiaki Kato
This figure shows the co-authorship network connecting the top 25 collaborators of Fumiaki Kato. A scholar is included among the top collaborators of Fumiaki Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiaki Kato. Fumiaki Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 38 | |
| 4 | 14 | |
| 5 | 6 | |
| 6 | 9 | |
| 7 | 7 | |
| 8 | 21 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 28 | |
| 13 | 1 | |
| 14 | 13 | |
| 15 | 12 | |
| 16 | 7 | |
| 17 | 8 | |
| 18 | 2 | |
| 19 | 5 | |
| 20 | 21 |
About Fumiaki Kato
Fumiaki Kato is a scholar working on Internal Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 34 papers that have together received 330 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (13 papers), Pleural and Pulmonary Diseases (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (242 citations), Internal Medicine (25 citations) and Cardiology and Cardiovascular Medicine (103 citations). Fumiaki Kato has collaborated with scholars based in Japan and United States. Frequent co-authors include Koichiro Tatsumi, Rintaro Nishimura, Seiichiro Sakao, Nobuhiro Tanabe, Kazuki Nabeshima, Akinori Iwasaki, Makoto Hamasaki, Ayumi Sekine, Takayuki Jujo and Rika Suda. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Physiology-Lung Cellular and Molecular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.